Our mission: To develop safer and more effective immunotherapies through innovations in drug delivery. Avidea Technologies is a leader in the development of polymer-based drug delivery systems with immunotherapeutic applications. Our technology and team are building on more than two decades of pioneering work by our world-class scientific founders and advisors from the National Institutes of Health, the University of Oxford and the Institute for Macromolecular Chemistry. Our founders, advisors and collaborators are experts in the fields of immunology, oncology, vaccines and drug-delivery. We apply the interdisciplinary expertise of our team to overcome key challenges in drug delivery and advance promising immunotherapies to patients in need.